Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
HRSA Revises RWHAP Policy Notice on Eligibility Determinations
In October 2021, HRSA's HIV/AIDS Bureau revised its client eligibility and recertification policy for the Ryan White HIV/AIDS Program.
News Article updated on 11/02/2021 -
HRSA Releases New Fact Sheets on RWHAP Clients
Ten fact sheets on client populations getting care from the Ryan White HIV/AIDS Program (RWHAP) a
News Article updated on 06/30/2021 -
Merging Prevention and Care Planning Groups
HIV planning groups are responsible for overseeing the planning and implementation of HIV prevention and care activities within communities. Historically, prevention and care programs have operated separate planning groups. RWHAP Part A and Part B recipients and CDC-funded prevention jurisdictions have conducted parallel planning activities, oftentimes with little collaboration or coordination. As a way to reduce duplicative planning activities and streamline the work of planning groups, a number of jurisdictions have integrated their HIV planning groups.
Resource updated 09/14/2023
-
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Online Course on Integrated Planning
-
Lights, Camera, Action: Introducing an Integrated HIV Prevention and Care Planning Online Course
Introduction to the newly developed online course, An Introduction to Integrated HIV Prevention and Care Planning.Resource updated 02/28/2022
-
Identifying and Incorporating into Practice Screening Tools for People with HIV who are Aging in the Ryan White HIV/AIDS Program
This HRSA HIV/AIDS Bureau national webinar featured two Ryan White HIV/AIDS Program (RWHAP) providers.
Resource updated 06/09/2022
-
An Introduction to HIV Prevention and Care Planning
This self-paced course from the Integrated HIV/AIDS Planning TA Center serves as an introduction to the fundamentals of integrated planning, and is designed for anyone who is new to integrated HIV prevention and care planning or anyone who would like a refresher on the basics.
By the end of this course, you will be able to:
Resource updated 07/28/2021
-
HIV Planning Body Assessment Guide: A Resource for Integrated HIV Planning Bodies
Guide to help integrated HIV planning bodies review and evaluate the effectiveness of their structure, policies and procedures, membership, and stakeholder and consumer engagement.Resource updated 09/14/2023
-
RWHAP Part C and D Stakeholders Webinar - July 2021
Session covered program updates and Centering Care for Women, Children, and Adolescents across the HIV Care Continuum.Resource updated 01/10/2024
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Fostering Equity in HIV Planning
In this webinar, panelists discussed the ways in which power imbalances can manifest in HIV planning bodies; how their planning bodies have sought to promote equity; and strategies that can be implemented to foster equity and mitigate power imbalances based on race, education, age, and socioeconomic status.
Resource updated 11/22/2021
-
Medical Monitoring Project 2019-2020 Data on HIV Care Access and Health Outcomes
In the U.S., almost all people with HIV have some type of health insurance coverage (pub
News Article updated on 08/09/2021 -
Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic
Recap of changes made in telehealth laws, regulations, and policies and corresponding efforts of healthcare systems, payers, and providers to modify their services to keep clients with HIV engaged in care provided by HRSA's Ryan White HIV/AIDS Program.Resource updated 06/09/2022
-
Reflections on COVID-19 Driven Telehealth Implementation in the RWHAP
The HRSA white page Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic offers lessons for future service delivery.Blog updated 01/23/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
An Update on COVID-19
Review of COVID-19 risks in people with HIV (PWH), covering: risks; vaccination and prevention measures; and treatment considerations.Resource (Conference Presentation) updated 09/14/2023
-
40 Years of Progress: Looking Back at the Beginning of the HIV/AIDS Epidemic in the Bay Area
Moderated discussion (Saag, Cheever) of those that were involved at the very start of the HIV/AIDS epidemic in the San Francisco Bay Area.
Panelists: Kathleen A. Clanon, MD, Director, Alameda Care Connect; Marcus A. Conant, MD, Co-founder, San Francisco AIDS Foundation; Alison Moed, RN, Head Nurse, AIDS Ward, San Francisco General Hospital; Michael Reyes, MD, University of California San Francisco; Paul A. Volberding, MD, University of California San Francisco.
Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023